Description
Bankruptcy Auction! Bid Deadline: November 17, 2023
DNAtrix
- Clinical-stage biotechnology company focusing on the development of cutting edge, virus-driven immunotherapies for difficult-to-treat cancers.
- 15 granted patents protecting the intellectual property behind drugs and Immunotherapy process in the U.S, Canada, Europe and Asia. Heavily Differentiated and patented Immunology approach with progressive drugs.
- Significant cash flow potential both internally and through out-licensing products.
Top Therapies & Top Clinical Trial Status:
•Company Website: https://www.dnatrix.com/
For Access to Full Data Room, please complete and execute the Confidentiality Agreement/NDA posted on this website, and then email to Jolshin@AuctionAdvisors.com. Upon our receipt ofteh executed agreement, you will receive an invitation via email to access the SecureDocs Data room.
Documents
Auction Information
Due Diligence Information
* Requires confirmation of Online Agreement
Terms & Conditions
- Buyers Premium:
NA (see Bidding Procedures)
- Closing:
Later of (i) 30-days of Auction; and (ii) 15 days after Court approval. See Bidding Procedures.
- Deposit Amount:
10% of Bid Amount. See Bidding Procedures.
- Broker Co-op:
NA
Inspection
Qualifying Bid Deadline: November 17, 2023 @ 12:00 PM ET
Auction Information
Due Diligence Information
* Requires confirmation of Online Agreement
- Buyers Premium:
NA (see Bidding Procedures)
- Closing:
Later of (i) 30-days of Auction; and (ii) 15 days after Court approval. See Bidding Procedures.
- Deposit Amount:
10% of Bid Amount. See Bidding Procedures.
- Broker Co-op:
NA
Qualifying Bid Deadline: November 17, 2023 @ 12:00 PM ET